Orphanet: Pesquisa simples
x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

118 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
FREIBURG

Ensaio a decorrerSIPA-SOS: An open label phase II study of Sirolismus in patients with segmental overgrowth syndrome
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Pädiatrische Hämatologie und Onkologie

ALEMANHA

Hessen
FRANKFURT AM MAIN

CANADA

Ontario
TORONTO

ESPANHA

Andalucía
MÁLAGA

ESPANHA

Andalucía
SEVILLA

ITALIA

LAZIO
ROMA

Ensaio em fase de recrutamentoEnsaio a decorrerA Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and/or Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
Ambulatorio Polispecialistico per le Malattie Rare

ITALIA

LOMBARDIA
PAVIA

Ensaio em fase de recrutamentoEnsaio a decorrerFinanciado por um membro do IRDiRCEffect of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilatation in patients with Marfan syndrome mutation carriers of the gene FBN1
Fondazione IRCCS Policlinico San Matteo
Laboratorio di Diagnostica Molecolare, Patologia Cardiovascolare e dei Trapianti

ALEMANHA

Niedersachsen
HANNOVER

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

ESPANHA

Madrid
MADRID

Ensaio a decorrerSetmelanotide (RM-493): Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Endocrinología, Crecimiento y Metabolismo

ESTADOS UNIDOS

Ohio
CINCINNATI

Ensaio em fase de recrutamentoEnsaio a decorrerFinanciado por um membro do IRDiRCQuercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1/2) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

FRANCA

AUVERGNE-RHONE-ALPES
LYON

Ensaio a decorrerVETCOSED: Effectiveness of Wearing a Compression Garment (SED CICATREX® Model) for Patients With Hypermobility Type of Ehlers-Danlos Syndrome
Centre Médico-Chirurgical de Réadaptation des Massues - Croix-Rouge française
Médecine physique et réadaptation Adultes

FRANCA

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Ensaio em fase de recrutamentoEnsaio a decorrerNOVASED: Efficiency Clinical Study of NOVATEX MEDICAL Compression Garments in Patients With Ehlers-Danlos Syndrome.
CHU de Nancy - Hôpitaux de Brabois
Service de médecine interne et immunologie clinique

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerARCADE: Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Placebo Controlled, Multicenter Trial (Phase III) - FR
CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
Service de génétique - CR des Maladies Vasculaires Rares

ITALIA

LOMBARDIA
MILANO

Ensaio a decorrerAn Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa (phase III) - IT
IRCCS Ca' Granda - Ospedale Maggiore Policlinico - Clinica Pediatrica De Marchi
U.O.S. di Infettivologia Pediatrica

REINO UNIDO

Merseyside
LIVERPOOL

Ensaio a decorrerEffects of exenatide on appetite and ghrelin levels in patients with Prader-Willi Syndrome
Fazakerley Hospital
University Hospital Aintree - Diabetes and Endocrinology

REINO UNIDO

West Midlands
BIRMINGHAM

ALEMANHA

Baden-Württemberg
FREIBURG

Ensaio a decorrerFinanciado por um membro do IRDiRCMCDS-Therapy: An open label phase I/IIa trial repurposing carbamazepine (CBZ) for the treatment of skeletal dysplasia in children - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Sektion Pädiatrische Genetik der Klinik für Allgemeine Kinder- und Jugendmedizin

ALEMANHA

Nordrhein-Westfalen
KÖLN

Ensaio a decorrerUni-Koeln-1574: Translational therapy in patients with Osteogenesis imperfecta - a pilot trial on treatment with the RANKL-antibody Denosumab (Phase II)
Universitätsklinikum Köln
Pädiatrische Endokrinologie, Stoffwechselstörungen, Osteologie und Rheumatologie

BELGICA

ANTWERPEN
ANTWERPEN-EDEGEM

Ensaio em fase de recrutamentoEnsaio a decorrerFinanciado por um membro do IRDiRCMCDS-Therapy: An open label phase I/IIa trial repurposing carbamazepine (CBZ) for the treatment of skeletal dysplasia in children - BE
Centrum Medische Genetica - UZA
Centrum Medische Genetica - Het Universitair Ziekenhuis Antwerpen

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ESPANHA

Comunidad Valenciana
VALENCIA

FRANCA

AUVERGNE-RHONE-ALPES
BRON

Ensaio em fase de recrutamentoEnsaio a decorrerPROFIDYS: Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (Phase II -III) - FR
Hospices Civils de Lyon - Groupement Hospitalier EST
Service de rhumatologie et de pathologie osseuse

FRANCA

AUVERGNE-RHONE-ALPES
BRON

Ensaio em fase de recrutamentoEnsaio a decorrerTREATMENT OF FIBROUS DYSPLASIA OF BONE WITH TOCILIZUMAB AMONG PATIENTS WHO DO NOT RESPOND TO BISPHOSPHONATES. THE TOCIDYS TRIAL (Phase II) - FR
Hospices Civils de Lyon - Groupement Hospitalier EST
Service de rhumatologie et de pathologie osseuse

REINO UNIDO

Edinburgh
EDINBURGH

REINO UNIDO

Grampian
ABERDEEN

Ensaio a decorrerPROFIDYS : Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (Phase II/III)
TauRx Therapeutics - Institute of Medical Sciences
Department of Medicines and Therapeutics

REINO UNIDO

Greater London
LONDON

REINO UNIDO

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

Ensaio a decorrerFinanciado por um membro do IRDiRCMCDS-Therapy: An open label phase I/IIa trial repurposing carbamazepine (CBZ) for the treatment of skeletal dysplasia in children-GB
Freeman Hospital, The newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust

ESPANHA

Comunidad Valenciana
VALENCIA

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio (s) clínico (s) multinacional (ais)

ESPANHA

Madrid
MADRID

Financiado por um membro do IRDiRCEUROFANCOLEN: Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
CIEMAT - Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
Terapias innovadoras en el sistema hematopoyético